[{"id":"2ac2d1d3-f211-480d-b318-f1f6e888d604","acronym":"CLINCH","url":"https://clinicaltrials.gov/study/NCT05718895","created_at":"2023-02-08T17:00:25.766Z","updated_at":"2024-07-02T16:35:10.403Z","phase":"Phase 1","brief_title":"A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors","source_id_and_acronym":"NCT05718895 - CLINCH","lead_sponsor":"Antengene Biologics Limited","biomarkers":" CLDN18","pipe":"","alterations":" ","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ATG-022"],"overall_status":"Recruiting","enrollment":" Enrollment 156","initiation":"Initiation: 03/27/2023","start_date":" 03/27/2023","primary_txt":" Primary completion: 06/30/2026","primary_completion_date":" 06/30/2026","study_txt":" Completion: 06/30/2026","study_completion_date":" 06/30/2026","last_update_posted":"2024-04-10"}]